Halozyme COVID-19 Response

To Our Shareholders: 2019 Year in Review
Homepage

Science

ENHANZE® Technology

HYLENEX® recombinant

(hyaluronidase human injection)

Careers

Investors

About Us

Useful Links

Contact Info


Office:

Halozyme
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: 858.794.8889
info@halozyme.com

Recent News

June 29, 2020 Halozyme Announces Roche Receives FDA Approval For Phesgo™ (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
June 22, 2020 Halozyme To Receive $10 Million Milestone Payment From Janssen
June 17, 2020 Halozyme To Participate In The BMO 2020 Prescriptions For Success Healthcare Conference
Copyright© 2015-2019. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.
Powered By Q4 Inc. 5.36.0.1

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok